David Jackson, MD, MBA
Global Medical Director
David Jackson, MD, MBA, is the Global Medical Director at the Ivy Brain Tumor Center, where he plays an essential role in advancing our mission to transform brain tumor care. With a deep commitment to patient safety and advancing neuro-oncology research, Dr. Jackson oversees pivotal late-phase clinical trials, providing comprehensive medical expertise across clinical operations, regulatory affairs, medical affairs, and biostatistics. His leadership ensures that clinical studies are conducted with the highest standards, prioritizing the safety and well-being of all participants.
Dr. Jackson completed postdoctoral training in clinical research at Harvard Medical School. He holds a medical degree from All Saints University School of Medicine in Toronto, Canada, and an executive MBA and bachelor’s in biology from the University of Memphis.
Dr. Jackson’s extensive background in global clinical development spans over a decade, with leadership roles at prominent biotech firms such as Sirtex Medical, Rigel Pharmaceuticals, and Lundbeck Pharmaceuticals. As a physician-scientist, he is passionate about fostering a patient-focused culture and developing next-generation therapies in neurology and oncology. His diverse therapeutic expertise includes neuro-oncology, immuno-oncology, neurodegenerative diseases (Alzheimer’s, Parkinson’s, Huntington’s), CNS disorders, gene cell therapy, hematology and advanced liver therapies.